Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy.
The pharmacogenomics journal 2015 Oct 15 (5): 397-404.
Paré-Brunet L, Sebio A, Salazar J, Berenguer-Llergo A, Río E, Barnadas A, Baiget M, Páez
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 22, 2019
- Content source: